Literature DB >> 7950335

Human vitreous penetration of imipenem.

J P Adenis1, M Mounier, J L Salomon, F Denis.   

Abstract

The purpose of this study was to determine imipenem concentrations in vitreous humor of non-infected human eyes. Ten patients undergoing vitrectomy were infused with a single dose of either 0.5g (5 patients) or 1g (5 patients) of imipenem. Vitreous humor was withdrawn 2 or 4 hours after the end of the infusion. Results differed in relation to the dose. After 0.5g, vitreous levels were stable (approximately 0.20 mg/l), but after 1g they were significantly higher (approximately 2 mg/l). These levels were above the minimum inhibitory concentration of imipenem for 90% (MIC 90) of the main species responsible for endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7950335     DOI: 10.1177/112067219400400207

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  5 in total

Review 1.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

2.  Modeling approach to characterize intraocular doripenem pharmacokinetics after intravenous administration to rabbits, with tentative extrapolation to humans.

Authors:  Oudy Semoun; Sandrine Marchand; Nicolas Grégoire; Isabelle Lamarche; Christophe Adier; Laurent Laroche; Pablo Goldschmidt; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

Review 3.  Antimicrobial guide to posterior segment infections.

Authors:  Tapan P Patel; David N Zacks; Vaidehi S Dedania
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-06       Impact factor: 3.117

4.  Intravenous treatment of experimental Staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime and amikacin.

Authors:  Michael Engelbert; Herminia Miño de Kaspar; Martina Mette; Martin Thiel; Christopher N Ta; Thomas Grasbon; Markus Schulze-Schwering; Volker Klauss; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-14       Impact factor: 3.117

Review 5.  The Role of Systemic Antimicrobials in the Treatment of Endophthalmitis: A Review and an International Perspective.

Authors:  Andrzej Grzybowski; Magdalena Turczynowska; Stephen G Schwartz; Nidhi Relhan; Harry W Flynn
Journal:  Ophthalmol Ther       Date:  2020-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.